Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-23T10:59:21.966Z Has data issue: false hasContentIssue false

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGENDUM

Published online by Cambridge University Press:  28 September 2023

Rights & Permissions [Opens in a new window]

Abstract

Type
Corrigendum
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. The Association for Clinical and Translational Science

The above abstract published with mistakes in some author names and affiliations. Some authors names were not included in the author list at all.

The correct list of authors and their affiliations is as follows:

Harriet T Rothschild1, A Jo Chien2, Rachel C Jankowitz3, Mark JM Magbanua4, Jason A Mouabbi5, Rebecca A Shatsky6, Julia Levine7 and Rita A Mukhtar8

1School of Medicine, University of California, San Francisco, 2Department of Medicine, University of California, San Francisco, 3Department of Medicine, University of Pennsylvania, 4Department of Laboratory Medicine, University of California, San Francisco, 5Department of Breast Medical Oncology, MD Anderson Cancer Center, 6Department of Medicine, University of California, San Diego, 7Lobular Breast Cancer Alliance and 8Department of Surgery, University of California, San Francisco

The original abstract has been corrected online to rectify these errors.

References

Rothschild, H., Jankowitz, R., Shatsky, R., Mouabbi, J., Levine, J., & Jo Chien, A. (2023). 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: Identifying new markers of disease progression. Journal of Clinical and Translational Science, 7(S1), 14–14. doi: 10.1017/cts.2023.142.CrossRefGoogle Scholar